Clinical Trial Update: A Study of Niacin Regulation [EARLY_Phase 1]

View source ↗

Summary

This early phase 1 study, sponsored by Mayo Clinic, is investigating niacin regulation as a potential approach to treat obesity and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Niacin Regulation

Snippet

Sponsor: Mayo Clinic | Conditions: Excessive Weight Gain | EARLY_Phase 1 | Status: RECRUITING